Trial Profile
Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2013
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- 08 Feb 2013 New trial record